Cockeysville, MD, United States of America

Jai-He Li

This inventor holds 2 USPTO granted patents. Top assignee: Gpi Nil Holdings Inc.. Active years: 2000-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jai-He Li. Retrieved from https://idiyas.com/inventor/jai-he-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2000-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Jai-He Li

Introduction

Jai-He Li is an accomplished inventor based in Cockeysville, MD (US). He has made significant contributions to the field of neurotrophic compounds, holding a total of 2 patents. His work focuses on the development of small molecule N-linked sulfonamides of heterocyclic thioesters.

Latest Patents

Jai-He Li's latest patents include innovative compounds that have potential therapeutic applications. One of his notable inventions is related to N-linked sulfonamides of heterocyclic thioesters, which possess an affinity for FKBP-type immunophilins. This invention aims to inhibit the enzyme activity associated with immunophilin proteins, particularly targeting peptidyl-prolyl isomerase, or rotamase, enzyme activity.

Career Highlights

Throughout his career, Jai-He Li has demonstrated a commitment to advancing scientific knowledge and developing new therapeutic agents. His work has implications for various medical applications, particularly in the field of neurobiology.

Collaborations

Jai-He Li has collaborated with notable colleagues, including Gregory S. Hamilton and Wei Huang, contributing to a dynamic research environment that fosters innovation.

Conclusion

Jai-He Li's contributions to the field of neurotrophic compounds through his patents highlight his role as a significant inventor. His work continues to pave the way for advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…